Munté Muñiz Gerard, Lopez Montesinos Inmaculada, Padilla León Eduardo, Ramírez Marinero Aida Esperanza, Montero Milagro, Sorli Luisa, Duran Jorda Xavier, Horcajada Juan P
Hospital del Mar, Barcelona, Spain; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
Laboratori de Referència de Catalunya (LRC), Barcelona, Spain.
Enferm Infecc Microbiol Clin (Engl Ed). 2025 Jun-Jul;43(6):323-330. doi: 10.1016/j.eimce.2024.10.009.
To determine the prevalence of and risk factors for extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) faecal carriage among healthy volunteers from Barcelona, and to estimate the pooled prevalence in the community in Spain.
University students were asked to complete a questionnaire and provide a rectal swab, which was tested for ESBL-producing, ciprofloxacin- and trimethoprim-sulfamethoxazole-resistant Enterobacterales. Risk factors for carriage of antimicrobial resistance were identified by multivariate logistic regression. To place these results in the appropriate context, a systematic literature search was conducted to retrieve articles containing data on the prevalence of ESBL-PE faecal carriage in the community in Spain. To obtain the pooled prevalence, a random-effects meta-analysis was performed.
One hundred and thirty-five of 214 participants were included in the analysis. Faecal carriage of Escherichia coli/Klebsiella pneumoniae (E/K) resistant to at least one of the antibiotics tested was found in 32 participants (23.7%). Fourteen subjects carried ESBL-E/K (10.4%), with the CTX-M type being the most prevalent (85.7%). Risk factors for ESBL carriage were travel to a high-risk region in the past 3 years (OR 5.66; 95% CI 1.07-29.9) and living in a crowded city district (OR 6.91; 95% CI 1.22-39.08). Thirteen articles covering 21,760 individuals from Spain were included in the meta-analysis, giving a pooled prevalence rate for ESBL-PE carriage in the community of 5.8% (95% CI 4.1-7.8%), and a steady increase per year.
The faecal colonisation prevalence by ESBL-PE among healthy individuals in Spain is high. It is associated with international travel and living in crowded city districts.
确定巴塞罗那健康志愿者中产超广谱β-内酰胺酶肠杆菌科细菌(ESBL-PE)粪便携带情况的患病率及其危险因素,并估计西班牙社区的合并患病率。
邀请大学生填写问卷并提供直肠拭子,检测产ESBL、对环丙沙星和甲氧苄啶-磺胺甲恶唑耐药的肠杆菌科细菌。通过多因素逻辑回归确定抗菌药物耐药性携带的危险因素。为将这些结果置于适当背景下,进行了系统文献检索,以获取包含西班牙社区ESBL-PE粪便携带患病率数据的文章。为获得合并患病率,进行了随机效应荟萃分析。
214名参与者中有135名纳入分析。32名参与者(23.7%)的粪便中携带对至少一种测试抗生素耐药的大肠埃希菌/肺炎克雷伯菌(E/K)。14名受试者携带产ESBL-E/K(10.4%),其中CTX-M型最为常见(85.7%)。ESBL携带的危险因素为过去3年前往高风险地区(比值比5.66;95%置信区间1.07-29.9)和居住在拥挤的城市地区(比值比6.91;95%置信区间1.22-39.08)。荟萃分析纳入了13篇涵盖西班牙21760人的文章,社区中ESBL-PE携带的合并患病率为5.8%(95%置信区间4.1-7.8%),且每年稳步上升。
西班牙健康个体中ESBL-PE的粪便定植患病率较高。它与国际旅行和居住在拥挤的城市地区有关。